SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (2684)9/13/1999 10:16:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 4676
 
Isis Pharmaceuticals and Abbott Laboratories Establish Manufacturing Collaboration for Antisense Drugs. As I said in earlier notes from the CC, the CEO came across as extremely bullish on 2302 for Crohns. biz.yahoo.com

ISIP now 13 1/2 x 13 9/16. 103k shares traded in 1st 30 minutes. Looks like we have a breakout from the 2 year declining trendline. Will be even more important if ISIP, goes higher, retraces but holds at the old trendline. IMSCO Scott

some pig